clinical trial · NCT04832087
Pediatric Teduglutide Registry
Short Bowel SyndromeTeduglutide
brief summary
Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.
started
May 18, 2021
primary completion
Aug 31, 2023
completion
Aug 31, 2023
last updated
Dec 11, 2023
detailed description
This will be a multi-center post-marketing pediatric registry study evaluating the efficacy and safety of teduglutide. This is an observational longitudinal registry of pediatric SBS patients who are using FDA approved teduglutide as per standard of care.
official title
Pediatric Teduglutide Registry: Clinical Use of Teduglutide in Children With Intestinal Failure, a Multicenter Post-marketing Evaluation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol